|
OMUCR-1 cells
|
9.93 nM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
NRH-LS1 cells
|
47 nM
|
Cell viability was measured using the Luminescent Cell Viability Assay. Relative IC50 for 120 h was calculated using a four-parameter logistic function based on non-linear regression analysis using SigmaPlot.
|
Download PDF
|
|
UPS cell lines (SHEF UPS01, SHEF UPS02, SHEF UPS03, SHEF UPS04, IEC-56)
|
0.632 lM (average), 0.022 –1.490 lM (range)
|
PrestoBlue reagent reduction, Spark 20 M plate reader, Prism 10 software
|
Download PDF
|
|
SNU-16
|
approximately 150 nM
|
ATPlite assay
|
Download PDF
|
|
KKU-213A
|
5.31 ±0.2 μM
|
SRB assay
|
PMC11126846
|
|
IMR32
|
1.44 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
SK-N-BE(2)
|
1.56 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
NGP
|
1.62 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
SK-N-AS
|
1.78 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
SK-N-SH
|
1.85 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
LA155N
|
2.01 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
SH-SY5Y
|
2.15 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
CHP134
|
2.23 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
Kelly
|
2.34 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
CHP212
|
2.56 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
NB-10
|
3.12 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
SJ-NB-10
|
6.25 μM
|
Modified methyl thiazolyl tetrazolium (MTT) assays and continuous live cell imaging (IncuCyte® Zoom TM system) for cell viability and confluence.
|
Download PDF
|
|
T-ALL cells
|
1 μM
|
Dose-response curves
|
Download PDF
|
|
KG-1 cells
|
1.4 µmol/L
|
CCK-8 method
|
PMC7342572
|
|
Huh-7
|
2359 nM (48 h), 1124 nM (72 h)
|
MTT assay
|
PMC4453944
|
|
ECs
|
>2500 nM (72 h)
|
MTT assay
|
PMC4453944
|
|
HSCs
|
>2500 nM (72 h, constitutive); 462 nM (72 h, bFGF stimulatio
|
MTT assay
|
PMC4453944
|